Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | CTACK | 20.0 | 55 | |
| N2586 | PI103 | 0.1 | uM | 1 | CTACK | 16.0 | 49 | ||||
| RA2159 | IL-6 | 100 | ug/mL | 1 | CTACK | 18.0 | 56 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 19.0 | 63 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 19.0 | 52 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 18.0 | 59 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 19.0 | 72 | |
| RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 17.5 | 62 | |
| RA2159 | Sigma A6730 | 3.0 | uM | 1 | CTACK | 16.0 | 82 | ||||
| N2586 | IL-6 | 100 | ug/mL | 1 | CTACK | 22.0 | 63 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 20.0 | 57 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 20.0 | 53 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 17.5 | 46 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 21.0 | 51 | |
| N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | CTACK | 22.5 | 42 | |
| N2586 | Sigma A6730 | 3.0 | uM | 1 | CTACK | 20.0 | 45 | ||||
| RA2159 | IL-17A | 100 | ng/mL | 1 | CTACK | 17.0 | 69 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 17.0 | 65 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 15.5 | 62 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 18.0 | 81 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 19.0 | 72 | |
| RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 18.0 | 61 | |
| N2586 | IL-17A | 100 | ng/mL | 1 | CTACK | 23.0 | 39 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 19.0 | 36 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | CTACK | 26.0 | 28 |